Fig. 7
From: Comprehensive tumor molecular profile analysis in clinical practice
Simulation of the 990 PCAWG samples’ categorization based on their most clinically significant variant when the analysis is performed using either the 161 the 514 gene panels. The following categories were used: Tier 1 variants: patients carrying at least one Tier 1 alteration, 2C.1: patients whose most clinically significant variant is classified as 2C.1, 2C.2: patients with 2C.2 alterations, 2D: patients with 2D alterations, Tier 3: patients carrying Tier 3 alterations